3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
NIH
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Leukemia
40
Lymphoma
39
Melanoma
27
Leukemia, Lymphocytic, Chronic, B-Cell
27
Lymphoma, Non-Hodgkin
24
Lymphoma, Follicular
24
Precursor Cell Lymphoblastic Leukemia-Lymphoma
23
Breast Neoplasms
21
Lymphoma, Large B-Cell, Diffuse
20
Lymphoma, Mantle-Cell
19
Myelodysplastic Syndromes
17
Neuroblastoma
16
Lymphoma, Large-Cell, Immunoblastic
16
Hodgkin Disease
16
Multiple Myeloma
15
Leukemia, Myeloid, Chronic-Phase
15
Leukemia, Myeloid, Acute
15
Burkitt Lymphoma
15
Lymphoma, B-Cell, Marginal Zone
14
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
14
Prostatic Neoplasms
13
Neoplasm Metastasis
13
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
11
Neoplasms, Plasma Cell
10
Leukemia, Myeloid, Accelerated Phase
10
Glioblastoma
10
Congenital Abnormalities
10
Carcinoma, Ovarian Epithelial
9
Ovarian Neoplasms
8
Interventions
Cisplatin
101
Radiotherapy
53
Brachytherapy
41
Paclitaxel
37
Carboplatin
36
Surveys and Questionnaires
28
Blood Specimen Collection
20
pembrolizumab
19
Radiation
17
Magnetic Resonance Spectroscopy
17
Drug Therapy
17
Colposcopy
16
Methods
14
Bevacizumab
14
Early Intervention, Educational
12
toripalimab
11
Topotecan
11
Radiotherapy, Intensity-Modulated
11
Papanicolaou Test
11
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
11
Chemoradiotherapy
11
Biopsy
11
camrelizumab
10
Mass Screening
10
Gemcitabine
10
Patient Navigation
9
Papillomavirus Vaccines
9
Nivolumab
9
Fluorodeoxyglucose F18
9
Educational Status
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Uterine Cervical Neoplasms
×
sargramostim
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled